MedTrace Logo

Financial and Insurance Assistance- Oncology Financial and Legal Navigation Program

NCT05876325 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 61

Last updated 2024-07-22

No results posted yet for this study

Summary

The overall objective of this study was to develop and evaluate FINassist (Financial and Insurance Navigation Assistance), a patient-centered, interdisciplinary team-based oncology financial and legal navigation program. The program leverages Medical Legal Partnerships to enhance cost of care conversations with pediatric oncology patients and caregivers. FINassist optimizes the team-based care model by integrating clinicians, social workers, financial navigators, and legal advocates who work in tandem to enhance cost of care conversations with patients and caregivers, identify and intervene on patient socio-legal needs, and advocate for system-level changes.

Conditions

  • Financial Stress
  • Pediatric Cancer

Interventions

OTHER

FINassist Patient

The FINassist intervention provides access to social, financial and legal services over the duration of 12 months or until issues are resolved

OTHER

FINassist Caregiver

The FINassist intervention provides access to social, financial and legal services over the duration of 12 months or until issues are resolved

Sponsors & Collaborators

  • Robert Wood Johnson Foundation

    collaborator OTHER

  • Jean Edward

    lead OTHER

Principal Investigators

  • Jean Edward, PhD, RN · University of Kentucky

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-04-01
Primary Completion
2022-09-01
Completion
2022-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05876325 on ClinicalTrials.gov